4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-050000
Director bought 2,396 shares at $2.50 ($5,990)
From the SEC's structured data for this filing
Trades in this filing
ANDREWS DEBORAH J · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-21 | Purchase : show line 1 in the form | +2,396 | $2.50 | $5,990 | 8,396 | D |
| Open-market purchases · 2,396 sh · avg $2.50 · $5,990 | ||||||
Loading xslF345X03/doc4.xml…